stoxline Quote Chart Rank Option Currency Glossary
  
LifeStance Health Group, Inc. (LFST)
6.17  0.15 (2.49%)    03-28 16:00
Open: 6
High: 6.34
Volume: 1,340,693
  
Pre. Close: 6.02
Low: 5.975
Market Cap: 2,349(M)
Technical analysis
2024-03-28 4:52:39 PM
Short term     
Mid term     
Targets 6-month :  9.27 1-year :  10.74
Resists First :  7.94 Second :  9.19
Pivot price 6.37
Supports First :  5.9 Second :  4.91
MAs MA(5) :  6.02 MA(20) :  6.64
MA(100) :  6.72 MA(250) :  7.4
MACD MACD :  -0.3 Signal :  -0.2
%K %D K(14,3) :  8.5 D(3) :  5.2
RSI RSI(14): 42.5
52-week High :  9.59 Low :  4.73
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ LFST ] has closed above bottom band by 37.2%. Bollinger Bands are 0.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.35 - 6.37 6.37 - 6.4
Low: 5.91 - 5.94 5.94 - 5.97
Close: 6.13 - 6.17 6.17 - 6.21
Company Description

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.

Headline News

Wed, 27 Mar 2024
LifeStance Health Group (LFST) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Movies Canada

Sun, 24 Mar 2024
Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST) - Simply Wall St

Thu, 21 Mar 2024
LifeStance Health Group, Inc. Revenue Breakdown – NASDAQ:LFST – TradingView - TradingView

Tue, 19 Mar 2024
LifeStance Health CEO sells over $1.3 million in company stock By Investing.com - Investing.com

Tue, 19 Mar 2024
Analyst Rating: Will Lifestance Health Group Inc (LFST) Stock Beat the Market? - InvestorsObserver

Mon, 11 Mar 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group ... - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 381 (M)
Shares Float 86 (M)
Held by Insiders 13 (%)
Held by Institutions 86.7 (%)
Shares Short 27,160 (K)
Shares Short P.Month 25,900 (K)
Stock Financials
EPS -0.51
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.76
Profit Margin -17.7 %
Operating Margin -28 %
Return on Assets (ttm) -5.2 %
Return on Equity (ttm) -12.7 %
Qtrly Rev. Growth 22.2 %
Gross Profit (p.s.) 0
Sales Per Share 2.78
EBITDA (p.s.) -0.26
Qtrly Earnings Growth 0 %
Operating Cash Flow -17 (M)
Levered Free Cash Flow 14 (M)
Stock Valuations
PE Ratio -12.1
PEG Ratio 0
Price to Book value 1.63
Price to Sales 2.21
Price to Cash Flow -139.16
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android